Unraveling the Mechanisms Behind Behavioral Side Effects of Common Weight Loss Medications
Glucagon-like peptide 1 receptor agonists, commonly known as GLP1RAs, have emerged as significant pharmacological agents in the management of type 2 diabetes and obesity. Over...